Edwards Lifesciences Operating Margin 2010-2025 | EW

Current and historical operating margin for Edwards Lifesciences (EW) over the last 10 years. The current operating profit margin for Edwards Lifesciences as of March 31, 2025 is 28.04%.
Edwards Lifesciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $5.52B $1.43B 25.81%
2024-12-31 $5.44B $1.38B 25.35%
2024-09-30 $5.08B $1.36B 26.76%
2024-06-30 $4.97B $1.38B 27.66%
2024-03-31 $4.88B $1.27B 26.02%
2023-12-31 $5.01B $1.31B 26.12%
2023-09-30 $4.43B $1.22B 27.46%
2023-06-30 $4.51B $1.25B 27.79%
2023-03-31 $4.58B $1.45B 31.60%
2022-12-31 $4.46B $1.50B 33.58%
2022-09-30 $5.36B $1.68B 31.23%
2022-06-30 $5.36B $1.66B 31.06%
2022-03-31 $5.36B $1.75B 32.57%
2021-12-31 $5.23B $1.69B 32.30%
2021-09-30 $5.10B $1.67B 32.72%
2021-06-30 $4.93B $1.64B 33.19%
2021-03-31 $4.48B $0.92B 20.63%
2020-12-31 $4.39B $0.90B 20.45%
2020-09-30 $4.37B $0.86B 19.62%
2020-06-30 $4.32B $0.79B 18.35%
2020-03-31 $4.48B $1.23B 27.45%
2019-12-31 $4.35B $1.15B 26.38%
2019-09-30 $4.15B $0.83B 20.01%
2019-06-30 $3.97B $0.79B 19.82%
2019-03-31 $3.82B $0.77B 20.15%
2018-12-31 $3.72B $0.75B 20.11%
2018-09-30 $3.64B $1.06B 29.13%
2018-06-30 $3.55B $1.04B 29.24%
2018-03-31 $3.45B $1.04B 30.02%
2017-12-31 $3.44B $1.09B 31.74%
2017-09-30 $3.32B $0.96B 28.86%
2017-06-30 $3.23B $0.92B 28.58%
2017-03-31 $3.15B $0.89B 28.25%
2016-12-31 $2.96B $0.78B 26.43%
2016-09-30 $2.87B $0.79B 27.46%
2016-06-30 $2.74B $0.75B 27.27%
2016-03-31 $2.60B $0.68B 26.14%
2015-12-31 $2.49B $0.64B 25.78%
2015-09-30 $2.44B $0.62B 25.32%
2015-06-30 $2.43B $0.59B 24.34%
2015-03-31 $2.39B $0.56B 23.60%
2014-12-31 $2.32B $0.49B 21.23%
2014-09-30 $2.24B $0.47B 21.03%
2014-06-30 $2.13B $0.45B 21.00%
2014-03-31 $2.07B $0.46B 21.97%
2013-12-31 $2.05B $0.47B 23.12%
2013-09-30 $2.02B $0.49B 24.16%
2013-06-30 $1.97B $0.48B 24.19%
2013-03-31 $1.94B $0.45B 23.03%
2012-12-31 $1.90B $0.42B 22.12%
2012-09-30 $1.82B $0.36B 20.01%
2012-06-30 $1.78B $0.33B 18.44%
2012-03-31 $1.73B $0.31B 17.77%
2011-12-31 $1.68B $0.30B 17.87%
2011-09-30 $1.64B $0.29B 17.92%
2011-06-30 $1.58B $0.30B 19.09%
2011-03-31 $1.51B $0.30B 19.85%
2010-12-31 $1.45B $0.29B 19.70%
2010-09-30 $1.40B $0.27B 19.19%
2010-06-30 $1.38B $0.26B 18.78%
2010-03-31 $1.35B $0.25B 18.37%
2009-12-31 $1.32B $0.24B 18.07%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $44.464B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $189.818B 83.14
Thermo Fisher Scientific (TMO) United States $156.486B 18.93
Alcon (ALC) Switzerland $43.874B 29.65
IDEXX Laboratories (IDXX) United States $42.296B 48.61
DexCom (DXCM) United States $33.259B 51.41
IQVIA Holdings (IQV) United States $27.640B 15.48
Mettler-Toledo (MTD) United States $25.284B 30.07
STERIS (STE) Ireland $23.842B 26.26
Waters (WAT) United States $20.819B 29.37
SONOVA HOLDING (SONVY) Switzerland $18.720B 0.00
Hologic (HOLX) United States $14.516B 15.77
Sysmex ADR (SSMXY) Japan $10.481B 29.73
Penumbra (PEN) United States $9.903B 77.73
Masimo (MASI) United States $9.110B 33.61
Globus Medical (GMED) United States $8.322B 19.83
Teleflex (TFX) United States $5.543B 9.15
Glaukos (GKOS) United States $5.465B 0.00
TransMedics (TMDX) United States $4.764B 103.57
Integer Holdings (ITGR) United States $4.275B 22.40
PROCEPT BioRobotics (PRCT) United States $3.554B 0.00
LivaNova (LIVN) United Kingdom $2.595B 15.45
Veracyte (VCYT) United States $2.183B 30.64
Nihon Kohden (NHNKY) Japan $2.111B 24.21
Elekta AB (EKTAY) Sweden $1.910B 17.17
Alphatec Holdings (ATEC) United States $1.785B 0.00
Tandem Diabetes Care (TNDM) United States $1.495B 0.00
Artivion (AORT) United States $1.249B 116.96
Pulse Biosciences (PLSE) United States $1.167B 0.00
OPKO Health (OPK) United States $1.094B 0.00
Integra LifeSciences Holdings (IART) United States $1.086B 5.78
Beta Bionics (BBNX) United States $0.835B 0.00
SiBone (SIBN) United States $0.814B 0.00
IRadimed (IRMD) United States $0.762B 38.67
RxSight (RXST) United States $0.638B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.597B 9.29
Mesa Laboratories (MLAB) United States $0.569B 13.34
Delcath Systems (DCTH) United States $0.565B 0.00
OrthoPediatrics (KIDS) United States $0.538B 0.00
AxoGen (AXGN) United States $0.486B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.453B 0.00
AngioDynamics (ANGO) United States $0.452B 0.00
NeuroPace (NPCE) United States $0.424B 0.00
Treace Medical Concepts (TMCI) United States $0.388B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
Semler Scientific (SMLR) United States $0.351B 9.35
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
908 Devices (MASS) United States $0.255B 0.00
Neuronetics (STIM) United States $0.249B 0.00
Tactile Systems Technology (TCMD) United States $0.241B 14.58
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Sight Sciences (SGHT) United States $0.216B 0.00
Anteris Technologies Global (AVR) Australia $0.193B 0.00
Biosig Technologies (BSGM) United States $0.182B 0.00
Inogen (INGN) United States $0.178B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
CVRx (CVRX) United States $0.170B 0.00
Rapid Micro Biosystems (RPID) United States $0.157B 0.00
LENSAR (LNSR) United States $0.152B 0.00
Lucid Diagnostics (LUCD) United States $0.141B 0.00
Accuray (ARAY) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.096B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.084B 51.30
EnVVeno Medical (NVNO) United States $0.076B 0.00
InspireMD (NSPR) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.064B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
Spectral AI (MDAI) United States $0.053B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Baird Medical Investment Holdings (BDMD) $0.027B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
NexGel (NXGL) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.37